The Cooper Companies, Inc. (COO)

Revenue

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jul 31, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015	Oct 31, 2014	Oct 31, 2013
Toric and Multifocal Revenue	1.42B	1.35B	1.26B
Sphere, Other Revenue	1.42B	1.39B	1.35B
Total CooperVision Revenue	2.85B	2.74B	2.61B
Office and Surgical Products Revenue	839.20M	824.00M	774.70M
Fertility Revenue	552.60M	524.60M	511.30M
Total CooperSurgical Revenue	1.39B	1.35B	1.29B
Revenue (Other)	-2.85B	-2.74B	-2.61B
Revenue (Total)	4.24B	4.09B	3.90B

Revenue by Geography

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jul 31, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015	Oct 31, 2014	Oct 31, 2013
United States Revenue	2.11B	2.05B	1.97B
Europe Revenue	1.36B	1.25B	1.16B
Rest Of The World Revenue	773.30M	785.20M	773.60M
Revenue (Total)	4.24B	4.09B	3.90B

EBIT

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jul 31, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015	Oct 31, 2014	Oct 31, 2013
CooperVision Operating Income	788.00M	729.60M	676.20M
CooperSurgical Operating Income	-153.40M	43.40M	118.30M
Corporate Operating Income	-90.40M	-90.10M	-88.80M
Operating Income (Total)	544.20M	682.90M	705.70M

Key Performance Indicators

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015	Oct 31, 2014	Oct 31, 2013
CooperVision - Constant Currency Revenue Growth	5.00%	8.00%
CooperSurgical - Constant Currency Revenue Growth	5.00%	11.00%
Total Company - Constant Currency Revenue Growth	5.00%	9.00%
CooperVision - Organic Revenue Growth	5.00%	9.00%
CooperSurgical - Organic Revenue Growth	3.00%	5.00%
Total Company - Organic Revenue Growth	4.00%	8.00%

Data Source: Fiscal.ai Last updated: Sep 9, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error